CXCL10 and asthma: Studies have shown IFNγ+ CD4+ T cells are more prevalent in the airways in severe asthma versus mild, moderate disease and that IFNγ-induced expression of CXCL10 and down-regulation of SLPI lead to increased AHR and steroid resistance in severe asthma (53, 54, 142, 143).